<< Back
Oct 24, 2014

Tandem Diabetes Care Announces Schedule Change for Third Quarter 2014 Earnings Press Release and Conference Call

SAN DIEGO, Oct. 24, 2014 (GLOBE NEWSWIRE) -- Tandem Diabetes Care®, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced a schedule change for its third quarter 2014 results. The company will now release its third quarter 2014 results before the financial markets open on Thursday, November 6, 2014. The Company will hold a conference call and simultaneous webcast on the same day at 11:00am Eastern Time (8:00am Pacific Time), to discuss its third quarter 2014 financial and operating results.

Conference Call/Webcast Details:

Date: November 6, 2014

Time: 11:00am Eastern Time (8:00am Pacific Time)

Toll Free Dial-In Number: 855-427-4396

International Dial-In Number: 484-756-4261

Conference ID: 15463574  

Webcast Link: http://www.media-server.com/m/p/gw8rsuoe

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Investor Events" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with insulin-dependent diabetes. The Company manufactures and sells the t:slim Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the first and only insulin pump with a high resolution, color touch screen. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim, #tconnect and $TNDM.

Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.

t:slim and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.

CONTACT: Media Contact:

         Steve Sabicer

         714-907-6264

         ssabicer@thesabicergroup.com



         Investor Contact:

         Susan Morrison

         858-366-6900 x7005

         smorrison@tandemdiabetes.com

Tandem Diabetes Care Logo

Source: Tandem Diabetes Care

News Provided by Acquire Media